Wednesday, July 8, 2026

biotech · Relapsed or Refractory B-cell Malignancies · Solid Tumor · RXRX

RECURSION PHARMACEUTICALS

RECURSION PHARMACEUTICALS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Staten Island, USA HQ
11 Employees
Public company Type
RXRX · NYSE Ticker
Company details
Status
Public
HQ
Staten Island, USA
Employees
11
Programs
9
Drugs
2
Patents
4
Intelligence · Clinical Trials

RECURSION PHARMACEUTICALS clinical trials

Registry index of 9 ClinicalTrials.gov studies linked to RECURSION PHARMACEUTICALS programs — each row shows trial ID, program name, phase, status, and indication.

RECURSION PHARMACEUTICALS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for RECURSION PHARMACEUTICALS.

  1. REC-4881 — Phase 2

    Clinical update
  2. EXS73565 — Phase 1

    Clinical update
  3. REC-2282 — Phase 3

    Clinical update
  4. GTAEXS617 — Phase 2

    Clinical update
  5. REC-1245 — Phase 2

    Clinical update
  6. REC-3964 — Phase 2

    Clinical update
  7. REC-4881 — Phase 2

    Clinical update
  8. REC-994 — Phase 2

    Clinical update

Trial registry

9 studies